←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Basal Cell Carcinoma
Gregory Guthrie
MD
🏢Regeneron Pharmaceuticals🌐USA
Clinical Investigator
20
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Gregory Guthrie supports clinical development of cemiplimab in advanced basal cell carcinoma after Hedgehog inhibitor failure. His work advances immune checkpoint blockade as a standard option for refractory BCC. He contributes to translational analysis in BCC trials.
Share:
🧪Research Fields 研究领域
basal cell carcinoma
cemiplimab
immunotherapy
clinical development
cutaneous cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Gregory Guthrie 的研究动态
Follow Gregory Guthrie's research updates
留下邮箱，当我们发布与 Gregory Guthrie（Regeneron Pharmaceuticals）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment